Discussion of standardized assessment and emergency treatment for hypersensitivity reactions in early clinical trials of anti-tumor monoclonal antibody drugs

FANG Ying-ying; LIU Long; LI Yin-juan; WANG Xing-he

doi:10.3969/j.issn.1003-3734.2021.24.012

Home>Articles>Discussion of standardized assessment and emergency treatment for hypersensitivity reactions in early clinical trials of anti-tumor monoclonal antibody drugs

DOI: 10.3969/j.issn.1003-3734.2021.24.012

Discussion of standardized assessment and emergency treatment for hypersensitivity reactions in early clinical trials of anti-tumor monoclonal antibody drugs

FANG Ying-ying

LIU Long

LI Yin-juan

WANG Xing-he

Machine-generated Keywords：

Publication Date：2021-12-31

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：5( 2295-2299 )

Chinese Journal of New Drugs

ISTICPKU

ISSN：1003-3734

Year, Vol.(Issue)：2021,30(24)